Victory Capital Management Inc Black Diamond Therapeutics, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$12.19 - $28.17 $124,374 - $287,418	-10,203 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$22.23 - $34.75 $12,604 - $19,703	-567 Reduced 5.26%	10,203 $248,000
Q4 2020 Feb 01, 2021	BUY	$29.47 - $35.0 $317,391 - $376,950	10,770 New	10,770 $345,000
Q3 2020 Nov 09, 2020	SELL	$26.17 - $43.07 $333,327 - $548,582	-12,737 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$22.3 - $44.8 $18,174 - $36,512	815 Added 6.84%	12,737 $537,000
Q1 2020 May 04, 2020	BUY	$18.18 - $39.48 $33,487 - $72,722	1,842 Added 18.27%	11,922 $297,000
Q4 2019 Feb 04, 2020	BUY	N/A	10,080 New	10,080 $378,000

119

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $90.1M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.